Janusz Rybakowski - Concepedia

Author

Janusz Rybakowski

Poznan University of Medical Sciences ORCID

Also Known As

Armida Mucci, J K Rybakowski, J M Fullerton, J RYBAKOWSKI, J Rybakowski, J. K. RYBAKOWSKI, J. K. Rybakowski, J. Rybakowski, J.K. Rybakowski, JANUSZ K. RYBAKOWSKI

915

Publications

20.4K

Citations

H-Index

188

Concepts

All Affiliations

Poznan University of Medical Sciences Dalhousie University Centro de Investigación Biomédica en Red de Salud Mental Technische Universität Dresden Universitat de Barcelona

About

Janusz Rybakowski is an author at Poznan University of Medical Sciences specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	114	7K
2	Social Sciences	35	78	4.3K
3	Health Sciences	7	7	181
4	Behavioral Sciences	6	6	261
5	Public Health	5	5	222

Janusz Rybakowski

250

Publications

14.5K

Citations

H-Index

Page 1

	Year	Citations
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial René S. Kahn, W. Wolfgang Fleischhacker, Han Boter, The Lancet First-episode SchizophreniaPsychiatryPsychotic DisorderPsychotropic MedicationAntipsychotic Drugs	2008	1.1K
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders Isabella Pacchiarotti, David J. Bond, Ross J. Baldessarini, American Journal of Psychiatry	2013	734
Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report Mirko Manchia, Mazda Adli, Nirmala Akula, PLoS ONE	2013	417
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study Liping Hou, Urs Heilbronner, Franziska Degenhardt, The Lancet Genome-wide Association StudyGenetic VariantsPsychiatryGeneticsPsychiatric Genetics	2016	392
Indicators of immune activation in major depression Janusz Rybakowski, Eugène Bosmans, Magdalena Sobieska, Psychiatry Research PsychoneuroimmunologyImmune ActivationPsychiatryMood SymptomImmunology	1996	386
Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST) Michael Davidson, Silvana Galderisi, Mark Weiser, American Journal of Psychiatry	2009	314
Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine A. Służewska, Janusz Rybakowski, M. Łaciak, Annals of the New York Academy of Sciences PsychoneuroimmunologyPsychiatryMood SymptomDepressionDepressed Patients	1995	304
Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder Siegfried Kasper, Göran Hajak, Katharina Wulff, The Journal of Clinical Psychiatry	2010	253
The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness Janusz Rybakowski, Katarzyna Twardowska Journal of Psychiatric Research Unipolar Affective IllnessStress HormonePsychiatryMood SymptomPsychology	1999	216
[Clinical pharmacokinetics of carbamazepine]. R Kanarkowski, Janusz Rybakowski PubMed Pharmacokinetic ModelingMedicinePharmacotherapyPharmacologyPharmacokinetics	1990	195

Page 1